ClinicalTrials.gov
public full text
Public Domain
Phase 3 Study to Evaluate the Efficacy & Safety of Self-Administered Injections of BMN165 by Adults With PKU
The BMN 165 clinical development program has been designed to demonstrate the safety and efficacy of BMN 165 in reducing blood Phe concentrations in adults with PKU.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- QH103 Cell Injection for the Treatment of Relapsed/Refractory B-cell Acute Lymphoblastic Leukemia#906077
- AAV Gene Therapy Study for Subjects with PKU#853578
- Pharmacokinetics and Safety of PBK-1801 After Single Oral Administration in Healthy Korean Women#861422
- A Phase 3 Clinical Trial to Evaluate the Efficacy and Safety of HCP1303 Capsules#872006
- A 16 Week Study Evaluating the Introduction of a GMP Based Protein Substitute in Participants With PKU#888245
Record · ID 852698
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive